Literature DB >> 6574820

Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer.

L A Kalman, M G Kris, R J Gralla, D P Kelsen, E S Casper, R T Heelan, R E Wittes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6574820

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Comparative activity of four anthracyclines against heterotransplanted germ cell tumor lines.

Authors:  A Harstrick; J Casper; H Köhne-Wömpner; H Wilke; H J Schmoll; H Poliwoda
Journal:  Invest New Drugs       Date:  1990       Impact factor: 3.850

2.  4'-EPI-doxorubicin in advanced lung cancer. A phase II trial.

Authors:  G Giaccone; M Donadio; G Bonardi; V Iberti; A Calciati
Journal:  Invest New Drugs       Date:  1990-11       Impact factor: 3.850

3.  Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.

Authors:  C Huisman; B Biesma; P E Postmus; G Giaccone; F M Schramel; E F Smit
Journal:  Br J Cancer       Date:  2001-11-16       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.